Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 3
2016 5
2017 1
2018 5
2019 6
2020 12
2021 7
2022 7
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Idiopathic pulmonary fibrosis: pathogenesis and management.
Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Sgalla G, et al. Respir Res. 2018 Feb 22;19(1):32. doi: 10.1186/s12931-018-0730-2. Respir Res. 2018. PMID: 29471816 Free PMC article. Review.
Pamrevlumab for the treatment of idiopathic pulmonary fibrosis.
Sgalla G, Franciosa C, Simonetti J, Richeldi L. Sgalla G, et al. Expert Opin Investig Drugs. 2020 Aug;29(8):771-777. doi: 10.1080/13543784.2020.1773790. Epub 2020 Jun 7. Expert Opin Investig Drugs. 2020. PMID: 32447983 Review.
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management.
Varone F, Iovene B, Sgalla G, Calvello M, Calabrese A, Larici AR, Richeldi L. Varone F, et al. Among authors: sgalla g. Lung. 2020 Jun;198(3):429-440. doi: 10.1007/s00408-020-00360-3. Epub 2020 May 15. Lung. 2020. PMID: 32415523 Review.
Residual respiratory impairment after COVID-19 pneumonia.
Lombardi F, Calabrese A, Iovene B, Pierandrei C, Lerede M, Varone F, Richeldi L, Sgalla G; Gemelli Against COVID-19 Post-Acute Care Study Group. Lombardi F, et al. Among authors: sgalla g. BMC Pulm Med. 2021 Jul 17;21(1):241. doi: 10.1186/s12890-021-01594-4. BMC Pulm Med. 2021. PMID: 34273962 Free PMC article.
Update in Pulmonary Fibrosis 2018.
Sgalla G, Kulkarni T, Antin-Ozerkis D, Thannickal VJ, Richeldi L. Sgalla G, et al. Am J Respir Crit Care Med. 2019 Aug 1;200(3):292-300. doi: 10.1164/rccm.201903-0542UP. Am J Respir Crit Care Med. 2019. PMID: 31022351 Review. No abstract available.
Antibody-based therapies for idiopathic pulmonary fibrosis.
Sgalla G, Flore M, Siciliano M, Richeldi L. Sgalla G, et al. Expert Opin Biol Ther. 2020 Jul;20(7):779-786. doi: 10.1080/14712598.2020.1735346. Epub 2020 Mar 2. Expert Opin Biol Ther. 2020. PMID: 32098521 Review.
COVID-related fibrosis: insights into potential drug targets.
Sgalla G, Comes A, Lerede M, Richeldi L. Sgalla G, et al. Expert Opin Investig Drugs. 2021 Dec;30(12):1183-1195. doi: 10.1080/13543784.2021.2010188. Epub 2021 Dec 1. Expert Opin Investig Drugs. 2021. PMID: 34842488 Review.
45 results